Ethylisopropyltryptamine (EiPT), also known as N-ethyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family. https://www.erowid.org/library/books_online/tihkal/tihkal10.shtml It is taken orally.
EiPT appears to have been first synthesized and described by Alexander Shulgin.
Use and effects In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose of EiPT as 24 to 40mg and its duration as 4 to 6hours. According to Shulgin, this compound tends to produce nausea, dysphoria, and other unpleasant side effects. It also seems to largely lack the hallucinatory and visual properties usually associated with psychedelic drugs.
Interactions
Chemistry EiPT is short for N-ethyl-N-isopropyltryptamine. The full chemical name of this structure is N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine. The compound is a substituted tryptamine, which all belong to a larger family of compounds known as indolethylamines.
Synthesis The chemical synthesis of EiPT has been described.
Analogues Analogues of EiPT include 4-HO-EiPT, 4-AcO-EiPT, 5-MeO-EiPT, methylisopropyltryptamine (MiPT), propylisopropyltryptamine (PiPT), ethylpropyltryptamine (EPT), diethyltryptamine (DET), and diisopropyltryptamine (DiPT), among others.
Society and culture Legal status United States EiPT is unscheduled and uncontrolled in the United States, but possession and sales of EiPT could be prosecuted under the Federal Analog Act because of its structural similarities to DET.
See also Substituted tryptamine
References
External links EIPT - Isomer Design EiPT - TiHKAL - Erowid EiPT - TiHKAL - Isomer Design